Marksans Pharma informs about press release

18 Oct 2016 Evaluate

Marksans Pharma has informed about a Press Release dated October 18, 2016 titled ‘Marksans Pharma Limited announces USFDA approval for Paricalcitol Capsules 1 mcg, 2 mcg and 4 mcg (ANDA 204948)’.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

178.90 -3.15 (-1.73%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×